Hawkins (NASDAQ:HWKN) Issues Earnings Results

Hawkins (NASDAQ:HWKN) released its quarterly earnings data on Wednesday. The specialty chemicals company reported $0.74 earnings per share for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02), FiscalAI reports. Hawkins had a return on equity of 16.85% and a net margin of 7.75%.The company had revenue of $265.91 million for the quarter, compared to analyst estimates of $255.28 million.

Hawkins Trading Down 3.9%

Shares of HWKN stock traded down $6.26 on Thursday, hitting $155.57. The stock had a trading volume of 175,467 shares, compared to its average volume of 163,665. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. The firm has a market capitalization of $3.25 billion, a P/E ratio of 39.32, a P/E/G ratio of 3.23 and a beta of 0.81. Hawkins has a 1 year low of $117.98 and a 1 year high of $186.15. The company’s 50 day moving average price is $153.61 and its 200-day moving average price is $146.15.

Hawkins Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, May 29th. Hawkins’s dividend payout ratio is 19.24%.

Institutional Investors Weigh In On Hawkins

Several institutional investors and hedge funds have recently modified their holdings of the company. Hsbc Holdings PLC purchased a new stake in shares of Hawkins in the 4th quarter valued at $221,000. Empowered Funds LLC raised its holdings in shares of Hawkins by 18.4% in the 4th quarter. Empowered Funds LLC now owns 2,072 shares of the specialty chemicals company’s stock valued at $294,000 after buying an additional 322 shares during the period. Uniplan Investment Counsel Inc. raised its holdings in shares of Hawkins by 9.3% in the 4th quarter. Uniplan Investment Counsel Inc. now owns 31,198 shares of the specialty chemicals company’s stock valued at $4,432,000 after buying an additional 2,650 shares during the period. Susquehanna Portfolio Strategies LLC purchased a new stake in shares of Hawkins in the 4th quarter valued at $1,212,000. Finally, Tudor Investment Corp ET AL purchased a new stake in shares of Hawkins in the 4th quarter valued at $1,994,000. Hedge funds and other institutional investors own 69.71% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. BWS Financial reaffirmed a “buy” rating and issued a $200.00 price target on shares of Hawkins in a research note on Monday, March 23rd. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Hawkins in a research note on Friday, April 10th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $200.00.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.